Similar results were shown in models of advanced atherosclerosis, in which annexin 1‐(2‐26) Collagen IV nanoparticles increased cap thickness and atherosclerotic plaques and reduced collagenase production, two key markers for atherosclerotic plaque progression (Fredman et al., 2015). Here, ANXA1 is linked to atherosclerosis.